REFERENCES
- Chiang C.-M., Cleary G. W. Skin permeation enhancer compositions. CA Pat. 2012875, 1990
- Gattefosse Company. Product Information, Transcutol Product Profile. Gattefosse Co.
- Yazdanian M., Chen E. The effect of diethylene glycol monoethyl ether as a vehicle for topical delivery of ivermectin. Vet. Res. Commun. 1995; 19: 309–319
- Pavliv L., Freeborn K., Wilke T., Chiang C.-C., Shetty B., Tyle P. Topical formulation development of a novel thymidylate synthase inhibitor for the treatment of psoriasis. Int. J. Pharm. 1994; 105: 227–233
- Panchagnula R., Ritschel W. A. Development and evaluation of an intracutaneous depot formulation of corticosteroids using Transcutol as a cosolvent: in-vitro, ex-vivo and in-vivo rat studies. J. Pharm. Pharmacol. 1991; 43(9)609
- Shaaya A. N., Kraus C., Bauman D. H, Ritschel W. A. Pharmacokinetics and bioavailability of papaverine HCl after intravenous, intracorporeal and penis topical administration in beagle dogs. Meth. Find Exp. Clin. Pharmacol. 1992; 14(5)373–378
- Ritschel W. A., Hussain A. S. In vitro skin permeation of griseofulvin in rat and human skin from an ointment dosage form. Arzneim-Forsch. 1988; 38(11)1630–1632
- Ash M., Ash I. Handbook of Industrial Surfactants. Gower, HantsEngland 1993; 84, compilers
- Wade A., Weller P. J. Handbook of Pharmaceutical Exciplents. 2nd ed, American Pharmaceutical Association, Washington, DC 1994